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Development of PDIA3 Knockout Human Osteosarcoma SaOs-2
Cells Using CRISPR-Cas9
Pyburn J, Razskazovskiy V, Hagg T, Keasey M.P.
A

Introduction:
Vitamin D signaling is involved in physiological calcification as well as in
pathological conditions such as Fahr’s disease (Keasey et al, 2016). The
discovery of Vitamin D’s in vitro role in calcification of human osteosarcoma
SaOs-2 cells has led to further exploration of Vitamin D related signalling. The
active metabolite of Vitamin D, calcitriol, exerts its intracellular effects
through its interaction with protein disulfide isomerase A3 (PDIA3) at the
plasma membrane. Using CRISPR-Cas9, the PDIA3 gene can be mutated in
cells to knock out protein expression.This allows for in vitro cell culture
manipulations to elucidate the role of calcitriol-PDIA3 signaling in calcification.
To better understand the role of PDIA3 mediated vitamin D signaling in
calcification, we chose to develop a cell line deficient in PDIA3 by CRISPRCas9. Using CHOP-CHOP, a gRNA selecting software which chooses
sequences with low predicted non-specific binding probabilities, we selected
gRNAs targeting exon 1 of PDIA3. The most specific gRNA was directionally
cloned into a Cas9 plasmid, which along with a puromycin resistance gene
plasmid, were transfected into SaOs cells. Subsequently, cells were treated
with puromycin to eliminate non-transfected cells. Next, we isolated multiple
homogenous populations of cells, each derived from a single transfected cell,
and the expression of PDIA3 mRNA and protein was quantified for each
colony. With successful confirmation of total PDIA3 knockout, further research
can now begin into how calcitriol-PDIA3 signaling relates to calcification in
vitro.

Figure 1: gRNA Selection Using CHOPCHOP Software

Figure 3: Ligation of guideRNA oligonucleotides into
pCas-Guide plasmid. (A) Restriction digest with BamHi
and BsmB I was followed by sticky end (red font) ligation
of gRNA oligonucleotides into pCas-Guide vectors .
Diagram B depicts the mapping of the genes for the
Cas9-gRNA expression plasmid.
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Methods:
Cloning: A gRNA targeting exon 1 of PDIA3 was created with the following
primers: forward 5‘GTGGCGCTGCTTCTTGCCG’3 and reverse
complementary 5‘CGGCAAGAAGCAGCGCCACA’3. For cloning of the gRNA
into the CRISPR-Cas9 plasmid, a “GATCG” overhang was appended to the
5’ end and “G” was appended to the 3’ end of the forward strand. For the
reverse strand “AAAC” was appended on the 5’ end and “C” was appended to
the 3’ end. Restriction enzymes BamH1 and BsmB1 were used to digest the
plasmid producing overhangs compatible with the annealed gRNA
oligonucleotide. Ligation was carried out using standard protocol and the
plasmid was amplified in DH5 E. Coli with ampicillin selection. Identity of the
plasmid was confirmed by agarose gel electrophoresis.
Cell culture: SaOs cells were maintained in DMEM supplemented with 10%
FBS and 2mM L-glutamine. The cells were housed in a T75 flask and were
passaged once reaching 90% confluency or every 3-4 days. After passaging,
2.0E6 cells were placed back in each flask, kept at 5% CO2 at 37°C.
qPCR:RNA was isolated using the OmegaBiotek RNEasy kit according to the
manufacturer’s protocol. qPCR was carried out as previously described
(Keasey et al, 2013) and analyzed using the ΔΔCT method.
Western blotting: Proteins were isolated in RIPA buffer supplemented with
PMSF and Western blotting was carried out as previously described (Keasey
et al, 2013). Primary and secondary antibody incubation was completed in
0.5% milk in TBST. Primary antibody dilutions were: ERp57-1:1000 and
GAPDH - 1:3000. The secondary antibody dilution was 1:5000.

Figure 2: (A) Transfection of Cells with Cas9-gRNA
plasmid and subsequent puromycin selection. (B)
Single cell colonies were picked for analysis of
PDIA3 mRNA expression. Here, it is seen that
colonies 2 and 10 display completely knocked out
PDIA3 mRNA expression. Colony 2 (red arrow) was
selected for further characterization and confirmation
of PDIA3 knockout.

Figure 4: Colony 2 was selected for further investigation. RT-qPCR (A) and
western blotting (B) confirm 100% knock out of PDIA3 in SaOs-2 cells
(p<0.001**, Student’s t-test, n=3). Brightfield images (C) demonstrate
morphology of wild type (WT) and PDIA3 KO cells.
Conclusion:
●
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PDIA3 protein was completely knocked out for use in further analysis and experimentation on the signaling of and the
role of Vitamin D in calcification processes in vitro.
After multiple passages, morphological differences have been observed between the SaOs-2 WT and SaOs-2 PDIA3
KO cells.
Future steps will include comparison of the ability of WT SaOs cells to undergo calcification relative to PDIA3 KO cells
as well as investigation into PDIA3’s role in regulating expression of mineral transporters involved in calcification.
Though it has been reported that whole organism knock out of PDIA3 is lethal at E13.5 in mice (Coe et al, 2009), our
PDIA3 KO SaOs cells successfully grow in culture.
Apoptosis and cellular growth rates remain to be characterized.

